Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03036683
Other study ID # EK 341/16
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2017
Est. completion date June 1, 2022

Study information

Verified date October 2022
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the effect of upregulating prefrontal cortex activity on risk-taking, and antisocial and aggressive behavior in violent offenders. In the double-blind, randomized controlled trial, using a within-subject crossover design, each participant will undergo anodal transcranial direct current stimulation of the right dorsolateral prefrontal cortex and sham stimulation. After each stimulation session, neural activity and behavioral responses to tasks assessing risk-taking and aggressive behavior will be recorded. The effect of tDCS on violent offenders will also be assessed in comparison to age and gender-matched healthy controls.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date June 1, 2022
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Between 18 and 50 years of age - Able to understand the nature of the study and give informed consent - Individuals in the violent offender group must have a record of repeated violent criminal offending (at least 2 felonies). - Individuals in the violent offender group must have been convicted solely due to crimes involving violence motivated by impulsive aggression. Exclusion Criteria: - Presence of any contraindications for functional magnetic resonance imaging (fMRI) - History of significant medical illness - History of any neurological condition - Diagnosis of schizophrenia - History of epilepsy - Head injury - Mental retardation

Study Design


Intervention

Device:
Transcranial direct current stimulation
Transcranial direct current stimulation will be administered for 20 minutes using a CE approved stimulator (NeuroConn, Ilmenau, Germany).
Sham transcranial direct current stimulation
The same device will be used as in the active stimulation group, but stimulation will be terminated after 30 seconds.

Locations

Country Name City State
Germany Uniklinik RWTH Aachen Aachen

Sponsors (2)

Lead Sponsor Collaborator
Olivia Choy RWTH Aachen University

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Klasen M, Zvyagintsev M, Schwenzer M, Mathiak KA, Sarkheil P, Weber R, Mathiak K. Quetiapine modulates functional connectivity in brain aggression networks. Neuroimage. 2013 Jul 15;75:20-26. doi: 10.1016/j.neuroimage.2013.02.053. Epub 2013 Mar 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of balloon pumps in the Balloon Analogue Risk Task after stimulation The number of balloon pumps, measured by the number of times subjects press a button to pump up a computerized balloon over 60 trials, will be assessed. Within 1 hour after the 20-minute tDCS or sham session ends
Primary Neural activity during Balloon Analogue Risk Task after stimulation Functional brain activity and connectivity will be assessed using functional magnetic resonance imaging. Within 1 hour after the 20-minute tDCS or sham session ends
Primary Aggressive behavior after stimulation This will be assessed according to performance on the violent video game, Carmageddon: TDR 2000 (Klasen et al., 2013; Torus Games, Bayswater, Australia, 2000) in comparison to a modified non-violent version of the game. Within 1 hour after the 20-minute tDCS or sham session ends
Primary Neural activity during aggression task after stimulation Functional brain activity and connectivity during participation in the video game will be assessed using functional magnetic resonance imaging. Within 1 hour after the 20-minute tDCS or sham session ends
Primary Antisocial behavior inclinations after stimulation This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will respond to the likelihood that they would commit the act in the scenario according to a 10-point Likert scale. Within 1 hour after the 20-minute tDCS or sham session ends
Secondary Number of participants with adverse events The number of participants reporting the experience of sensations resulting from tDCS will be recorded. Within 1 hour after the 20-minute tDCS or sham session ends
Secondary Ratings of guilt or shame regarding antisocial acts after stimulation This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will respond to the likelihood that they would feel a sense of guilt or shame according to a 10-point Likert scale. Within 1 hour after the 20-minute tDCS or sham session ends
Secondary Ratings of moral wrongfulness regarding antisocial acts after stimulation This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will rate the moral wrongfulness of the acts according to a 10-point Likert scale. Within 1 hour after the 20-minute tDCS or sham session ends
See also
  Status Clinical Trial Phase
Completed NCT02485587 - Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents N/A
Completed NCT02552147 - Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism Phase 1
Active, not recruiting NCT01792167 - Multi-Site Evaluation of Second Step N/A
Completed NCT00361062 - Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment N/A
Completed NCT00455234 - Rapid Tranquillization Trial: TREC-India II Phase 3
Completed NCT00000385 - Long-Term Lithium Treatment for Aggressive Conduct Disorder Phase 3
Not yet recruiting NCT03672942 - Communication Skills vs. Mindfulness for IPV N/A
Recruiting NCT04732052 - The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities N/A
Terminated NCT02483572 - Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control N/A
Completed NCT04097431 - Identifying Precursors to Severe Problem Behavior N/A
Completed NCT04130360 - A Trial of an Online Problem-solving Intervention for Aggression N/A
Completed NCT02563145 - Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents N/A
Completed NCT00510094 - Effectiveness of Treatment for Relational Aggression in Urban African American Girls Phase 3
Recruiting NCT03430973 - Aggressive Driving and Road Rage: A Driving Simulation Experiment. N/A
Completed NCT03693209 - Using Implementation Intentions to Reduce Anger and Aggression in Adolescence N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Completed NCT03784846 - Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers N/A
Active, not recruiting NCT04204759 - Transcranial Direct Current Stimulation and Antisocial Behavior N/A
Completed NCT01965184 - Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents N/A
Completed NCT04625465 - Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence N/A